Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Mar 13, 2024 | Sale | $2.06 | 26,247 | 53,990 | 905,447 | Mar 14, 2024, 09:33 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Mar 14, 2024 | Sale | $1.97 | 26,794 | 52,902 | 878,653 | Mar 14, 2024, 09:33 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Mar 13, 2023 | Sale | $2.80 | 25,356 | 70,997 | 658,070 | Mar 14, 2023, 07:56 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Mar 14, 2022 | Sale | $5.04 | 41,734 | 210,320 | 369,414 | Mar 15, 2022, 09:59 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Mar 15, 2021 | Sale | $6.38 | 37,149 | 236,925 | 204,639 | Mar 16, 2021, 07:43 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Dec 22, 2020 | Option Exercise | $4.32 | 56,105 | 242,400 | 188,440 | Dec 28, 2020, 05:44 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Operating Officer | Dec 22, 2020 | Sale | $8.00 | 56,105 | 448,840 | 135,003 | Dec 28, 2020, 05:44 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Commercial Officer | Dec 11, 2020 | Sale | $8.00 | 43,895 | 351,160 | 160,003 | Dec 15, 2020, 08:44 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Commercial Officer | Dec 11, 2020 | Option Exercise | $4.33 | 18,895 | 81,815 | 178,898 | Dec 15, 2020, 08:44 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Commercial Officer | Mar 17, 2020 | Sale | $3.59 | 23,500 | 84,475 | 138,912 | Mar 24, 2020, 09:24 PM | |
CERS | CERUS CORP | Jayaraman Vivek K | Chief Commercial Officer | Mar 13, 2019 | Sale | $5.90 | 5,979 | 35,274 | 75,163 | Mar 13, 2019, 08:45 PM | |
TRIV | TriVascular Technologies, Inc. | Jayaraman Vivek K | VP Global Sales and Marketing | Feb 03, 2016 | Option Exercise | $5.62 | 26,126 | 146,828 | 33,351 | Feb 04, 2016, 04:41 PM | |
TRIV | TriVascular Technologies, Inc. | Jayaraman Vivek K | VP Global Sales and Marketing | Feb 03, 2016 | Option Exercise | $2.43 | 47,778 | 116,101 | 54,048 | Feb 04, 2016, 04:41 PM |